Polymethoxyflavones and Bone Metabolism
Nutrients · 2025
DOI: 10.3390/nu17050822 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Michiko Hirata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakacho, Koganei-shi 184-8588, Tokyo, Japan. Hauptthemen laut MEDLINE: Bone and Bones, Bone Resorption, Flavones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI, Institute of Global Innovation Research.
Abstract (Originalsprache)
Phytochemicals, such as flavonoids, are bioactive compounds produced by plants, including citrus fruits, that exhibit antioxidant effects on mammalian cells and tissues. Polymethoxyflavones (PMFs) are a family of flavonoids found in the pulp and peel of citrus fruits, and have been reported to have potent antioxidant activity implicated in the prevention of human diseases. Several studies have shown that PMFs have a protective effect on bone resorption in mouse models of diseases, including osteoporosis, rheumatoid arthritis, and periodontal disease. PMFs significantly suppressed the differentiation of osteoclasts (bone resorptive cells) through indirect and direct mechanisms. The indirect effect of PMFs is the suppression of inflammatory mediator production, such as prostaglandin E2 (PGE2), and the reduction of osteoclastic inducers, such as the receptor activator of NF-κB ligand (RANKL), in osteoblasts (bone-forming cells). The direct effect of PMF suppresses osteoclast differentiation and function by inhibiting the NF-κB signaling pathway. In silico molecular docking studies indicated that PMFs target the ATP-binding pocket of IKKβ and inhibit the NF-κB signaling pathway. These findings suggest that PMFs protect against bone destruction by interfering with the NF-κB pathway in osteoblasts and osteoclasts. In this review, we summarize the latest findings regarding the effects of PMFs on various bone resorption-related diseases in mouse models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Nakacho, Koganei-shi 184-8588, Tokyo, Japan.
- Inada Research Unit, Institute of Global Innovation Research, Tokyo University of Agriculture and Technology, 2-24-16 Nakacho, Koganei-shi 184-8588, Tokyo, Japan.
- Institute of Crop Science and Resource Conservation, University of Bonn, Karlrobert-Kreiten-Strasse 13, 53115 Bonn, Germany.
ORCID-Profile: Tsukasa Tominari, Florian M W Grundler
Förderung
- Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI
- Institute of Global Innovation Research
Zitieren
APA
Hirata, M., Tominari, T., Matsumoto, C., Kasuga, U., Ikeda, K., Miyaura, C., Grundler, F. M. W., & Inada, M. (2025). Polymethoxyflavones and Bone Metabolism. Nutrients. https://doi.org/10.3390/nu17050822
Vancouver
Hirata M, Tominari T, Matsumoto C, Kasuga U, Ikeda K, Miyaura C, et al. Polymethoxyflavones and Bone Metabolism. Nutrients. 2025. doi:10.3390/nu17050822
BibTeX
@article{Hirata2025,
author = {Hirata, Michiko and Tominari, Tsukasa and Matsumoto, Chiho and Kasuga, Urara and Ikeda, Keisuke and Miyaura, Chisato and Grundler, Florian M W and Inada, Masaki},
title = {Polymethoxyflavones and Bone Metabolism},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17050822}
}
EUVIMED